395 related articles for article (PubMed ID: 19752273)
1. Role of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors.
Moura PA; Dame JB; Fidock DA
Antimicrob Agents Chemother; 2009 Dec; 53(12):4968-78. PubMed ID: 19752273
[TBL] [Abstract][Full Text] [Related]
2. Antimalarial synergy of cysteine and aspartic protease inhibitors.
Semenov A; Olson JE; Rosenthal PJ
Antimicrob Agents Chemother; 1998 Sep; 42(9):2254-8. PubMed ID: 9736544
[TBL] [Abstract][Full Text] [Related]
3. Hemoglobin Degrading Proteases of Plasmodium falciparum as Antimalarial Drug Targets.
Qidwai T
Curr Drug Targets; 2015; 16(10):1133-41. PubMed ID: 25738296
[TBL] [Abstract][Full Text] [Related]
4. Azole-based non-peptidomimetic plasmepsin inhibitors.
Kinena L; Leitis G; Kanepe-Lapsa I; Bobrovs R; Jaudzems K; Ozola V; Suna E; Jirgensons A
Arch Pharm (Weinheim); 2018 Sep; 351(9):e1800151. PubMed ID: 30063266
[TBL] [Abstract][Full Text] [Related]
5. Stage-specific antimalarial activity of cysteine protease inhibitors.
Shenai BR; Semenov AV; Rosenthal PJ
Biol Chem; 2002 May; 383(5):843-7. PubMed ID: 12108550
[TBL] [Abstract][Full Text] [Related]
6. Falcipains and other cysteine proteases of malaria parasites.
Rosenthal PJ
Adv Exp Med Biol; 2011; 712():30-48. PubMed ID: 21660657
[TBL] [Abstract][Full Text] [Related]
7. Biosynthesis and maturation of the malaria aspartic hemoglobinases plasmepsins I and II.
Francis SE; Banerjee R; Goldberg DE
J Biol Chem; 1997 Jun; 272(23):14961-8. PubMed ID: 9169469
[TBL] [Abstract][Full Text] [Related]
8. Falcipains, Plasmodium falciparum cysteine proteases as key drug targets against malaria.
Teixeira C; Gomes JR; Gomes P
Curr Med Chem; 2011; 18(10):1555-72. PubMed ID: 21428877
[TBL] [Abstract][Full Text] [Related]
9. Optimization of plasmepsin inhibitor by focusing on similar structural feature with chloroquine to avoid drug-resistant mechanism of Plasmodium falciparum.
Miura T; Hidaka K; Azai Y; Kashimoto K; Kawasaki Y; Chen SE; de Freitas RF; Freire E; Kiso Y
Bioorg Med Chem Lett; 2014 Apr; 24(7):1698-701. PubMed ID: 24631188
[TBL] [Abstract][Full Text] [Related]
10. Critical roles for the digestive vacuole plasmepsins of Plasmodium falciparum in vacuolar function.
Bonilla JA; Bonilla TD; Yowell CA; Fujioka H; Dame JB
Mol Microbiol; 2007 Jul; 65(1):64-75. PubMed ID: 17581121
[TBL] [Abstract][Full Text] [Related]
11. New class of small nonpeptidyl compounds blocks Plasmodium falciparum development in vitro by inhibiting plasmepsins.
Jiang S; Prigge ST; Wei L; Gao Ye ; Hudson TH; Gerena L; Dame JB; Kyle DE
Antimicrob Agents Chemother; 2001 Sep; 45(9):2577-84. PubMed ID: 11502532
[TBL] [Abstract][Full Text] [Related]
12. Antimalarial activities of novel synthetic cysteine protease inhibitors.
Lee BJ; Singh A; Chiang P; Kemp SJ; Goldman EA; Weinhouse MI; Vlasuk GP; Rosenthal PJ
Antimicrob Agents Chemother; 2003 Dec; 47(12):3810-4. PubMed ID: 14638488
[TBL] [Abstract][Full Text] [Related]
13. Dietary flavonoids fisetin and myricetin: dual inhibitors of Plasmodium falciparum falcipain-2 and plasmepsin II.
Jin H; Xu Z; Cui K; Zhang T; Lu W; Huang J
Fitoterapia; 2014 Apr; 94():55-61. PubMed ID: 24468190
[TBL] [Abstract][Full Text] [Related]
14. Deciphering the mechanism of potent peptidomimetic inhibitors targeting plasmepsins - biochemical and structural insights.
Mishra V; Rathore I; Arekar A; Sthanam LK; Xiao H; Kiso Y; Sen S; Patankar S; Gustchina A; Hidaka K; Wlodawer A; Yada RY; Bhaumik P
FEBS J; 2018 Aug; 285(16):3077-3096. PubMed ID: 29943906
[TBL] [Abstract][Full Text] [Related]
15. Gene disruption confirms a critical role for the cysteine protease falcipain-2 in hemoglobin hydrolysis by Plasmodium falciparum.
Sijwali PS; Rosenthal PJ
Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4384-9. PubMed ID: 15070727
[TBL] [Abstract][Full Text] [Related]
16. Development of Plasmodium falciparum protease inhibitors in the past decade (2002-2012).
Pérez B; Teixeira C; Gomes JR; Gomes P
Curr Med Chem; 2013; 20(25):3049-68. PubMed ID: 23514416
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of a Plasmodium vinckei cysteine proteinase cures murine malaria.
Rosenthal PJ; Lee GK; Smith RE
J Clin Invest; 1993 Mar; 91(3):1052-6. PubMed ID: 8450035
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in plasmepsin medicinal chemistry and implications for future antimalarial drug discovery efforts.
Meyers MJ; Goldberg DE
Curr Top Med Chem; 2012; 12(5):445-55. PubMed ID: 22242846
[TBL] [Abstract][Full Text] [Related]
19. Antimalarial effects of vinyl sulfone cysteine proteinase inhibitors.
Rosenthal PJ; Olson JE; Lee GK; Palmer JT; Klaus JL; Rasnick D
Antimicrob Agents Chemother; 1996 Jul; 40(7):1600-3. PubMed ID: 8807047
[TBL] [Abstract][Full Text] [Related]
20. Exploiting Structural Dynamics To Design Open-Flap Inhibitors of Malarial Aspartic Proteases.
Bobrovs R; Jaudzems K; Jirgensons A
J Med Chem; 2019 Oct; 62(20):8931-8950. PubMed ID: 31062983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
